Clinigen’s mission is to deliver the right medicine to the right patient at the right time, operating in three areas of global medicine supply: clinical trials, unlicensed and licensed medicines. In 2015 Clinigen acquired Idis, the global leader in the specialist management of ethical, regulatory compliant and efficient solutions to help pharmaceutical/biotech companies and healthcare professionals provide global access to medicines for patients with unmet medical need.

The trusted partner in providing ethical, compliant access to both unlicensed and commercial medicines in the regions of Asia, Africa and Australasia, supporting healthcare professionals and pharmaceutical industry partners to provide access to specialist and hard to access medicines.

Since 1997, Clinigen Clinical Supplies Management has offered a dynamic range of fully integrated services to meet the complex clinical supply challenges pharmaceutical and biotechnology companies face. Part of the Clinigen Group’s global supply chain facility and depot network, it combines market-leading clinical trial services such as comparator sourcing, packaging and labelling with biological sample management. Clinigen Clinical Supplies Management delivers tailored solutions for clients to ensure their clinical trials are a success, regardless of size or scope, from Phase I to Phase IV projects.

iQone is a specialty pharmaceutical company with medical and commercial operations across Europe and extensive experience in the set-up and delivery of both Managed Access and commercial solutions.